These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 21300912)

  • 1. PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice.
    Okazaki T; Okazaki IM; Wang J; Sugiura D; Nakaki F; Yoshida T; Kato Y; Fagarasan S; Muramatsu M; Eto T; Hioki K; Honjo T
    J Exp Med; 2011 Feb; 208(2):395-407. PubMed ID: 21300912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.
    Won TJ; Jung YJ; Kwon SJ; Lee YJ; Lee DI; Min H; Park ES; Joo SS; Hwang KW
    Arch Pharm Res; 2010 Nov; 33(11):1825-33. PubMed ID: 21116786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection.
    Richter K; Agnellini P; Oxenius A
    Int Immunol; 2010 Jan; 22(1):13-23. PubMed ID: 19880580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
    Gao W; Demirci G; Strom TB; Li XC
    Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical motifs in the cytoplasmic region of the inhibitory immune co-receptor LAG-3 inhibit T cell activation.
    Maeda TK; Sugiura D; Okazaki IM; Maruhashi T; Okazaki T
    J Biol Chem; 2019 Apr; 294(15):6017-6026. PubMed ID: 30760527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.
    Blackburn SD; Shin H; Haining WN; Zou T; Workman CJ; Polley A; Betts MR; Freeman GJ; Vignali DA; Wherry EJ
    Nat Immunol; 2009 Jan; 10(1):29-37. PubMed ID: 19043418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte Activation Gene-3 (LAG-3) negatively regulates environmentally-induced autoimmunity.
    Jha V; Workman CJ; McGaha TL; Li L; Vas J; Vignali DA; Monestier M
    PLoS One; 2014; 9(8):e104484. PubMed ID: 25122007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells.
    Raimondi G; Shufesky WJ; Tokita D; Morelli AE; Thomson AW
    J Immunol; 2006 Mar; 176(5):2808-16. PubMed ID: 16493037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of LAG-3 in PD-L1-Deficient Mice Enhances Clearance of Blood Stage Malaria Independent of Humoral Responses.
    Furtado R; Chorro L; Zimmerman N; Guillen E; Spaulding E; Chin SS; Daily JP; Lauvau G
    Front Immunol; 2020; 11():576743. PubMed ID: 33519801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad induction of immunoregulatory mechanisms after a short course of anti-IL-7Rα antibodies in NOD mice.
    Vazquez-Mateo C; Collins J; Fleury M; Dooms H
    BMC Immunol; 2017 Mar; 18(1):18. PubMed ID: 28356069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Trypanosoma cruzi-induced myocarditis by programmed death cell receptor 1.
    Gutierrez FR; Mariano FS; Oliveira CJ; Pavanelli WR; Guedes PM; Silva GK; Campanelli AP; Milanezi CM; Azuma M; Honjo T; Teixeira MM; Aliberti JC; Silva JS
    Infect Immun; 2011 May; 79(5):1873-81. PubMed ID: 21357717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New regulatory co-receptors: inducible co-stimulator and PD-1.
    Okazaki T; Iwai Y; Honjo T
    Curr Opin Immunol; 2002 Dec; 14(6):779-82. PubMed ID: 12413529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation.
    Meng Q; Yang P; Li B; Zhou H; Huang X; Zhu L; Ren Y; Kijlstra A
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4444-52. PubMed ID: 17003438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.
    Wang J; Yoshida T; Nakaki F; Hiai H; Okazaki T; Honjo T
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11823-8. PubMed ID: 16087865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues.
    Keir ME; Freeman GJ; Sharpe AH
    J Immunol; 2007 Oct; 179(8):5064-70. PubMed ID: 17911591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed death-1 ligands-transfected dendritic cells loaded with glutamic acid decarboxylase 65 (GAD65) inhibit both the alloresponse and the GAD65-reactive lymphocyte response.
    He FR; Zhu HF; Huang H; Dai YD; Shen X; Wang M; Li L; Xing W; Shen GX
    Clin Exp Immunol; 2008 Jan; 151(1):86-93. PubMed ID: 18005363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
    Zhang B; Chikuma S; Hori S; Fagarasan S; Honjo T
    Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8490-5. PubMed ID: 27410049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8+ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors.
    Mishra AK; Kadoishi T; Wang X; Driver E; Chen Z; Wang XJ; Wang JH
    Oncotarget; 2016 Dec; 7(49):81341-81356. PubMed ID: 27835902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-modulation of programmed death 1 alters regulatory T cells and promotes experimental autoimmune encephalomyelitis.
    Wang C; Li Y; Proctor TM; Vandenbark AA; Offner H
    J Neurosci Res; 2010 Jan; 88(1):7-15. PubMed ID: 19642196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced tumor eradication by combining CTLA-4 or PD-1 blockade with CpG therapy.
    Mangsbo SM; Sandin LC; Anger K; Korman AJ; Loskog A; Tötterman TH
    J Immunother; 2010 Apr; 33(3):225-35. PubMed ID: 20445343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.